Literature DB >> 21654057

Erythrocyte aggregation in patients with systemic lupus erythematosus.

M I Spengler1, M J Svetaz, M B Leroux, S M Bertoluzzo, P Carrara, F Van Isseldyk, D Petrelli, F M Parente, P Bosch.   

Abstract

Systemic Lupus Erythematosus (SLE) is an autoimmune, chronic inflammatory, non-organ specific disease. SLE patients present a high prevalence of thrombotic and arteriosclerotic disease. The aim of the present work was to study the erythrocyte aggregation kinetics, and the effect of plasma factors, namely, immunoglobulin and fibrinogen concentration, as well as cell factors such as deformability and erythrocyte membrane lipid fluidity on the erythrocyte aggregation, in SLE patients and healthy controls. The results show that SLE patients red blood cells aggregate at higher rate and the aggregates size are also greater than controls due to an increase of immunoglobulin and plasma fibrinogen. The negative correlation between aggregation parameters and rigidity index could point out that the altered deformability diminishes the erythrocyte aggregation. Correlation between rigidity index and anisotropy suggests that the decrease of membrane lipid fluidity might be a cause of deformability decrease. The erythrocyte aggregation increase in these patients could induce a decreased flow that might contribute to the thromboembolic process present in SLE patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654057     DOI: 10.3233/CH-2011-1409

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  8 in total

1.  Combined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM.

Authors:  Amit K Maiti; Xana Kim-Howard; Prasenjeet Motghare; Vandana Pradhan; Kek Heng Chua; Celi Sun; María Teresa Arango-Guerrero; Kanjaksha Ghosh; Timothy B Niewold; John B Harley; Juan-Manual Anaya; Loren L Looger; Swapan K Nath
Journal:  Hum Mol Genet       Date:  2014-03-07       Impact factor: 6.150

2.  An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus.

Authors:  Etheresia Pretorius; Jenny du Plooy; Prashilla Soma; Armen Yuri Gasparyan
Journal:  Rheumatol Int       Date:  2013-07-06       Impact factor: 2.631

3.  Influence of red blood cell aggregation on perfusion of an artificial microvascular network.

Authors:  Walter H Reinhart; Nathaniel Z Piety; Sergey S Shevkoplyas
Journal:  Microcirculation       Date:  2017-07       Impact factor: 2.628

Review 4.  Red blood cells: the forgotten player in hemostasis and thrombosis.

Authors:  J W Weisel; R I Litvinov
Journal:  J Thromb Haemost       Date:  2019-01-07       Impact factor: 5.824

5.  Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case-control study protocol.

Authors:  Péter Hegyi; Judit Bajor; Zsolt Szakács; Beáta Csiszár; Péter Kenyeres; Patrícia Sarlós; Bálint Erőss; Alizadeh Hussain; Ágnes Nagy; Balázs Kőszegi; Ibolya Veczák; Nelli Farkas; Emőke Bódis; Katalin Márta; Andrea Szentesi; Margit Tőkés-Füzesi; Tímea Berki; Áron Vincze; Kálmán Tóth
Journal:  BMJ Open       Date:  2019-03-23       Impact factor: 2.692

6.  Blood Viscosity in Subjects With Type 2 Diabetes Mellitus: Roles of Hyperglycemia and Elevated Plasma Fibrinogen.

Authors:  Jiehui Sun; Keqin Han; Miao Xu; Lujuan Li; Jin Qian; Li Li; Xuejin Li
Journal:  Front Physiol       Date:  2022-02-25       Impact factor: 4.566

Review 7.  Red blood cells in type 1 diabetes and multiple sclerosis and technologies to measure their emerging roles.

Authors:  M Geiger; E Hayter; R S Martin; D Spence
Journal:  J Transl Autoimmun       Date:  2022-08-07

8.  Adaptive optics-assisted identification of preferential erythrocyte aggregate pathways in the human retinal microvasculature.

Authors:  Shigeta Arichika; Akihito Uji; Sotaro Ooto; Kazuaki Miyamoto; Nagahisa Yoshimura
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.